We are live on ! Find out more

SSII

SS Innovations International

SSII

Market cap $579M

2.89 USD

-0.06

2.03%

At close Updated Sep 28, 4:00 PM EDT

1 day

-2.03%

5 days

-11.89%

1 month

-16.95%

3 months

-18.13%

6 months

-41.26%

Year to date

-48.85%

1 year

-48.85%

5 years

-74.54%

10 years

-74.54%

About: SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Employees: 483

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

SS Innovations Provides Update on Continuing Progress and Milestones

-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company's continuing progress and milestones.

SS Innovations Provides Update on Continuing Progress and Milestones

SS Innovations Reports Second Quarter 2026 Financial Results

Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

IBN Initiates Coverage of SS Innovations International, Inc.

AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN , a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.

IBN Initiates Coverage of SS Innovations International, Inc.

SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class

New course empowers healthcare professionals through expert instruction and hands-on learning New course empowers healthcare professionals through expert instruction and hands-on learning

SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class

SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

Company celebrated for advancing global access to its innovative robotic surgery platform Company celebrated for advancing global access to its innovative robotic surgery platform

SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

SS Innovations' Surgical Robotics Expansion Continues As Revenue More Than Doubles

SS Innovations (SSII) posted another quarter where revenue more than doubled compared to the prior year. Consistent sequential revenue acceleration highlights strong operational momentum following similar Q4 FY25 performance. Potential US and European regulatory approval provide significant asymmetric reward.

SS Innovations' Surgical Robotics Expansion Continues As Revenue More Than Doubles

SS Innovations Announces Completion of World's Longest-Distance Robotic Telesurgery

FORT LAUDERDALE, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that a robot-assisted heart procedure was successfully performed with the SSi Mantra surgical robotic system (the “SSi Mantra”) across approximately 12,500 miles (20,000 kilometers) of fiber network distance between Guyana and India, making it the world's longest-distance robotic telesurgery ever conducted.

SS Innovations Announces Completion of World's Longest-Distance Robotic Telesurgery

UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors

Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies. John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therapeutics, cancer care, longevity medicine, and pharmacogenetics – particularly within the rapidly growing direct-pay healthcare sector.

UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors

See News Rankings

Price charts implemented using Lightweight Charts™